Additionally, the study using integrative-omics analysis revealed that high S100A2 expression was frequently observed when KRAS was mutated, which has been known to induce a series of inflammatory cells 44, compared to BRAF mutated CRC cells line 45. This evidence concerns the gene S100A2 and colorectal carcinoma.